Ottawa Public Health (OPH) is warning residents that a highly toxic strain of opioids was detected in the city’s unregulated drug supply this week, which could lead to an increased risk of fatal overdoses. In a news release on Tuesday, OPH, Ottawa police, and Overdose Prevention and Response Task Force said Health Canada detected a substance called protonitazepyne in counterfeit pills circulating in Ottawa. “This drug is part of a class of drugs referred to as Nitazene opioids. Protonitazepyne is a toxic synthetic opioid about 25 times stronger than fentanyl and over 350 times stronger than morphine,” OPH said. The pills are meant to resemble prescription oxycodone tablets. They are blue and stamped with an ‘M’ on one side and the number 30 on the other side. “Authentic M30 30mg immediate-release oxycodone tablets are a U.S-marketed product that is not prescribed in Canada or authorized for sale by Health Canada,” OPH said. “Anyone seeing these pills circulating in the Ottawa drug supply should assume that they may contain highly toxic substances and pose an increased risk of overdose.” The overdoses caused by these drugs can cause a person to stop breathing and die. OPH adds that these types of overdoses may be difficult to treat and require more doses of naloxone than usual to reverse. How to respond to an overdose: Individuals who use drugs are reminded to carry naloxone, always use naloxone if you think someone is overdosing, don’t use alone, don’t mix drugs, and check drugs before using. Walk-in drug checking services are available at Sandy Hill Community Health Centre. When using, know your tolerance and go slow, as the toxicity of unregulated drugs is unpredictable. If you have a friend or family member who uses drugs, know the signs of an overdose and call 9-1-1 immediately if you witness an overdose and carry naloxone. According to public data, Ottawa Public Health has recorded 145 suspected overdose deaths between Dec. 29, 2025, and Nov. 7, 2026. Sixteen people died of a confirmed opioid overdose in the first three months of 2026, up from 12 the year prior, but down significantly from the peak of 74 confirmed opioid deaths in the first quarter of 2023.